• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Prescription surveillance for early detection system of emerging and reemerging infectious disease outbreaks

tetano

Editor, Senior Moderator
Biosci Trends. 2018;12(5):523-525. doi: 10.5582/bst.2018.01201.
[h=1]Prescription surveillance for early detection system of emerging and reemerging infectious disease outbreaks.[/h] Sugawara T[SUP]1[/SUP], Ohkusa Y[SUP]1[/SUP], Kawanohara H[SUP]2[/SUP], Kamei M[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Based on prescriptions filled at external pharmacies, prescription surveillance (PS) in Japan has been reporting the estimated numbers of influenza and varicella patients and people prescribed certain drugs since 2009. Every morning, this system estimates the numbers of patients from the numbers of prescriptions filled nationwide for neuraminidase inhibitors, anti-herpes virus drugs, antibiotic drugs, antipyretic analgesics, and multi-ingredient cold medications. Moreover, it can detect "unexplained" infectious diseases that are not explained as infectious diseases monitored by other surveillance systems. Such "unexplained" infectious diseases might be emerging and re-emerging infectious diseases including bioterrorism attacks, which are reportedly difficult to diagnose, at least in early outbreak stages. To ascertain the system's potential benefits, this study examined schemes to detect "unexplained" infectious diseases using PS information. The numbers of patients prescribed the respective drugs are first regressed on the known infectious diseases, time trends, and dummies for day-of-the-week, holidays, and days following a holiday. Known infectious diseases are defined as covered by the National Official Sentinel Surveillance for Infectious Diseases under the Infection Control Law. After the numbers of patients from PS are compared with the predicted numbers of patients, their probabilities of occurrence are calculated. We examined the system's prospective operation from January 2017 through July 2018. The criterion we used to define aberrations varied, from 0.01 to 10[SUP]-7[/SUP]. For criteria of 0.01 and 10[SUP]-7[/SUP] we found 254 and 15 aberrations, respectively. We confirmed its feasibility and effectiveness.


[h=4]KEYWORDS:[/h] National Official Sentinel Surveillance for Infectious Diseases; Prescription surveillance; bioterrorism attack; emerging and reemerging infectious disease; pharmacy

PMID: 30473564 DOI: 10.5582/bst.2018.01201
Free full text
 
Back
Top Bottom